Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in Mesenteric Venous Thrombosis

BACKGROUND: Monotherapy with anticoagulation has been considered as first-line therapy in patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate outcome, prognostic factors, and failure rate of anticoagulation as monotherapy, and to identify when bowel resection was...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., Acosta, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Scientific Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182753/
https://www.ncbi.nlm.nih.gov/pubmed/29777267
http://dx.doi.org/10.1007/s00268-018-4667-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182753/
https://www.ncbi.nlm.nih.gov/pubmed/29777267
http://dx.doi.org/10.1007/s00268-018-4667-x

Ejemplares similares